| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88836223 | FILING DATE | 03/16/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | VAGHANI, MAYUR C |
L.O. ASSIGNED | N60-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 10/29/2021 | ||
| PUB DATE | 03/02/2021 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 10/27/2021 | ||
| LITERAL MARK ELEMENT | KINISOQUIN | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | KINISOQUIN |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Quercis Pharma AG |
| ADDRESS | Nordstrasse 5 Zug, 6300 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19 |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| TRANSLATION | The wording "KINISOQUIN" has no meaning in a foreign language. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/29/2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 021 |
| 10/27/2021 | EX1G | S | EXTENSION 1 GRANTED | 020 |
| 10/27/2021 | EXT1 | S | EXTENSION 1 FILED | 019 |
| 10/27/2021 | EEXT | I | TEAS EXTENSION RECEIVED | 018 |
| 04/27/2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 017 |
| 03/02/2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 016 |
| 03/02/2021 | PUBO | A | PUBLISHED FOR OPPOSITION | 015 |
| 02/10/2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 014 |
| 01/22/2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 013 |
| 01/21/2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 01/20/2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 01/20/2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 07/30/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 009 |
| 07/30/2020 | GNRT | O | NON-FINAL ACTION E-MAILED | 008 |
| 07/30/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 007 |
| 07/17/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 07/17/2020 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 07/17/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 07/15/2020 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 03/20/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 03/19/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Victoria D Summerfield |
| CORRESPONDENCE ADDRESS | Victoria D Summerfield Troutman Pepper Hamilton Sanders LLP 501 Grant Street, Suite 300, Union Trust Pittsburgh PA 15219 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Quercis Pharma AG |
| ADDRESS | Nordstrasse 5 Zug, 6300 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Switzerland |